Skip to main content
. 2019 Nov 19;62(24):11035–11053. doi: 10.1021/acs.jmedchem.9b00742

Table 4. Effects of Compounds 39 and 43 in Chemokine-Stimulated [35S]GTPγS Bindinga.

receptor compd pEC50 ± SEM (EC50, nM) Emax ± SEM (%)b
hCCR2 CCL2 8.10 ± 0.06 (8) 107 ± 2
  CCL2 + 10 nM 39 7.89 ± 0.04 (13) 91 ± 1**
  CCL2 + 30 nM 39 7.60 ± 0.07 (26)** 75 ± 4****
  CCL2 + 100 nM 39 7.27 ± 0.10 (56)**** 50 ± 3****
  CCL2 + 1 nM 43 7.91 ± 0.10 (13) 72 ± 4****
  CCL2 + 3 nM 43 7.53 ± 0.12 (32)*** 51 ± 5****
  CCL2 + 10 nM 43 6.87 ± 0.13 (148)**** 33 ± 3****
hCCR5 CCL3 8.42 ± 0.06 (4) 108 ± 2
  CCL3 + 100 nM 39 8.35 ± 0.09 (5) 79 ± 5****
  CCL3 + 300 nM 39 8.14 ± 0.12 (8) 56 ± 2****
  CCL3 + 1000 nM 39 8.14 ± 0.17 (9) 25 ± 4****
  CCL3 + 30 nM 43 8.30 ± 0.05 (5) 81 ± 3****
  CCL3 + 100 nM 43 8.21 ± 0.05 (6) 58 ± 1****
  CCL3 + 300 nM 43 8.05 ± 0.06 (9)* 35 ± 2****
a

Data represent the mean ± standard error of the mean (SEM) of three independent experiments performed in duplicate. One-way ANOVA with Dunnett’s post hoc test was used to analyze differences in pEC50 and Emax values against CCL2 or CCL3 controls.

b

Maximum effect (Emax) of CCL2 or CCL3 measured in the absence or presence of fixed concentrations of compound 39 and 43 in CCR2 or CCR5, respectively.